BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27784533)

  • 41. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
    Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
    Kim HS; Kim JY; Park NH; Kim K; Chung HH; Kim YB; Kim JW; Kim HJ; Song YS; Kang SB
    Gynecol Oncol; 2010 Nov; 119(2):217-24. PubMed ID: 20705335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer.
    Li R; Hou WH; Chao J; Woo Y; Glaser S; Amini A; Nelson RA; Chen YJ
    J Natl Compr Canc Netw; 2018 Aug; 16(8):950-958. PubMed ID: 30099371
    [No Abstract]   [Full Text] [Related]  

  • 45. Survival analysis of Stage IIA1 and IIA2 cervical cancer patients.
    Lai JC; Chou YJ; Huang N; Tsai JJ; Huang SM; Yang YC; Chang CL; Wang KL
    Taiwan J Obstet Gynecol; 2013 Mar; 52(1):33-8. PubMed ID: 23548215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of pre-operative radiotherapy on long-term outcomes among women with Stage IB1 to IIB cervical squamous cell carcinoma.
    Liu P; Dai E; Li W; He F; Yang R; Bin X; Lang J; Chen C
    Int J Gynaecol Obstet; 2021 Jan; 152(1):125-132. PubMed ID: 33141931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
    OʼDonnell B; Shiao JC; Pezzi TA; Waheed N; Sharma S; Bonnen MD; Ludwig MS
    Int J Gynecol Cancer; 2018 Mar; 28(3):563-574. PubMed ID: 29324547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
    Seagle BL; Kanis M; Strohl AE; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting.
    Jung PS; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    PLoS One; 2015; 10(7):e0132298. PubMed ID: 26176626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study.
    Blohmer JU; Paepke S; Sehouli J; Boehmer D; Kolben M; Würschmidt F; Petry KU; Kimmig R; Elling D; Thomssen C; von Minckwitz G; Möbus V; Hinke A; Kümmel S; Budach V; Lichtenegger W; Schmid P
    J Clin Oncol; 2011 Oct; 29(28):3791-7. PubMed ID: 21860000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
    Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A clinical retrospective review of stage IB1 and IB2 cervical cancer].
    Shao S; Sun L; Sun L
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):66-8. PubMed ID: 11776803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
    Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
    Ann Surg Oncol; 2017 Apr; 24(4):1050-1056. PubMed ID: 27807728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oncological outcomes of combined therapy in patients with cervical carcinoma FIGO stage IIB].
    Kornovski Y; Ismail E; Kaneva M
    Akush Ginekol (Sofiia); 2012; 51(4):24-9. PubMed ID: 23234022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada.
    Kang YJ; O'Connell DL; Lotocki R; Kliewer EV; Goldsbury DE; Demers AA; Canfell K
    BMC Cancer; 2015 Sep; 15():642. PubMed ID: 26394749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
    Mabuchi S; Okazawa M; Isohashi F; Matsuo K; Ohta Y; Suzuki O; Yoshioka Y; Enomoto T; Kamiura S; Kimura T
    Gynecol Oncol; 2011 Nov; 123(2):241-7. PubMed ID: 21820708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
    Vargo JA; Patel A; Glaser SM; Balasubramani GK; Farah RJ; Marks SM; Beriwal S
    Cancer; 2017 Aug; 123(16):3176-3185. PubMed ID: 28380259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.